The REMIX project is focused on the cyclotron-based production of Sc-47, Tb-149, Tb-152, Tb-155 and Tb-161 radionuclides, whose decay characteristics make them suitable for medical applications. This work will outline the main results achieved withing the REMIX collaboration, that is organized in the following Work Packages (WP): WP1. Target manufacturing (Ti-49, Ti-50 and (Gd2O3)-Gd-155) and characterization; WP2. Nuclear cross section (XS) measurements with Ti-49 and Ti-50 targets for Sc-47 production; WP3. Nuclear XS measurements with Dy-nat, Tb-159 and Eu-nat targets for Tb-xx production; WP4. Nuclear XS modeling for Sc-47 and Tb-155 production; WP5. Dosimetric calculations for Sc-47- and Tb-xx-labelled radiopharmaceuticals; WP6. Tb-155 Thick Target Yield (TTY) measurements; WP7. Apparatus design and realization for irradiation tests with the LARAMED beamline. Since the LARAMED bunkers and ancillary laboratories are currently under completion at the INFN-LNL, the nuclear XS experiments are carried out in collaboration with the GIP ARRONAX facility (Saint-Herblain, France) and the Thick Target Yield (TTY) measurements are performed at the Sacro Cuore Don Calabria hospital (SCDCh, Negrar, Verona, Italy).

Research on Emerging Medical radionuclides from the X-sections (REMIX): The Accelerator-based Production of 47Sc, 149Tb, 152Tb, 155Tb and 161Tb

Barbaro, F;Bello, M;Cisternino, S;De Nardo, L;Sciacca, G;
2023

Abstract

The REMIX project is focused on the cyclotron-based production of Sc-47, Tb-149, Tb-152, Tb-155 and Tb-161 radionuclides, whose decay characteristics make them suitable for medical applications. This work will outline the main results achieved withing the REMIX collaboration, that is organized in the following Work Packages (WP): WP1. Target manufacturing (Ti-49, Ti-50 and (Gd2O3)-Gd-155) and characterization; WP2. Nuclear cross section (XS) measurements with Ti-49 and Ti-50 targets for Sc-47 production; WP3. Nuclear XS measurements with Dy-nat, Tb-159 and Eu-nat targets for Tb-xx production; WP4. Nuclear XS modeling for Sc-47 and Tb-155 production; WP5. Dosimetric calculations for Sc-47- and Tb-xx-labelled radiopharmaceuticals; WP6. Tb-155 Thick Target Yield (TTY) measurements; WP7. Apparatus design and realization for irradiation tests with the LARAMED beamline. Since the LARAMED bunkers and ancillary laboratories are currently under completion at the INFN-LNL, the nuclear XS experiments are carried out in collaboration with the GIP ARRONAX facility (Saint-Herblain, France) and the Thick Target Yield (TTY) measurements are performed at the Sacro Cuore Don Calabria hospital (SCDCh, Negrar, Verona, Italy).
2023
28th International Nuclear Physics Conference (INPC 2022)
28th International Nuclear Physics Conference (INPC 2022)
File in questo prodotto:
File Dimensione Formato  
Pupillo_2023_J._Phys.__Conf._Ser._2586_012118 - INPC 2022.pdf

accesso aperto

Tipologia: Published (publisher's version)
Licenza: Creative commons
Dimensione 866.43 kB
Formato Adobe PDF
866.43 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3505887
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
  • OpenAlex ND
social impact